Unaudited quarterly results for quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gayatri BioOrganics reported zero revenue from operations and zero total income for the third quarter as well as for the nine months ended December 31, 2025 — no business activity across periods. The company posted a net loss of ₹21.71 lakhs in Q3 FY26 versus a loss of ₹16.06 lakhs in Q3 FY25, with the nine-month loss widening to ₹69.13 lakhs from ₹55.19 lakhs a year ago. The company has negative net worth of ₹(3,589.31) lakhs against a paid-up equity capital of ₹7,878.81 lakhs, indicating accumulated losses have wiped out shareholder equity. Note 4 explicitly states the results are prepared on a going concern basis relying on a comfort letter from the promoters, signalling the company cannot sustain itself on its own operations.
This is a deeply negative filing for shareholders — the company has no revenue, recurring losses, fully eroded net worth, and its survival depends on promoter support. Expect continued pressure on the stock and heightened risk of trading suspension or deeper solvency concerns if no business restart or capital infusion is announced.